Compton Capital Management’s Edwards Lifesciences EW Stock Holding History

Compton Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,015	Closed	-$332K	–	80
2022 Q3	$332K	Sell	4,015 -200	-5%	-$19.2K	0.22%	65
2022 Q2	$401K	Sell	4,215 -400	-9%	-$41.4K	0.22%	71
2022 Q1	$543K	Sell	4,615 -200	-4%	-$22.4K	0.15%	109
2021 Q4	$624K	Hold	4,815	–	–	0.16%	100
2021 Q3	$545K	Hold	4,815	–	–	0.16%	105
2021 Q2	$499K	Sell	4,815 -50	-1%	-$4.71K	0.15%	109
2021 Q1	$407K	Hold	4,865	–	–	0.13%	121
2020 Q4	$444K	Hold	4,865	–	–	0.15%	102
2020 Q3	$388K	Hold	4,865	–	–	0.15%	101
2020 Q2	$336K	Buy	4,865 +50	+1%	+$3.55K	0.14%	105
2020 Q1	$303K	Buy	4,815 +600	+14%	+$43.3K	0.15%	100
2019 Q4	$328K	Hold	4,215	–	–	0.13%	112
2019 Q3	$309K	Sell	4,215 -8,175	-66%	-$574K	0.13%	113
2019 Q2	$763K	Hold	12,390	–	–	0.32%	78
2019 Q1	$790K	Sell	12,390 -675	-5%	-$38.5K	0.34%	73
2018 Q4	$667K	Sell	13,065 -450	-3%	-$22.8K	0.32%	80
2018 Q3	$784K	Hold	13,515	–	–	0.31%	81
2018 Q2	$656K	Hold	13,515	–	–	0.28%	87
2018 Q1	$629K	Sell	13,515 -450	-3%	-$19.5K	0.27%	93
2017 Q4	$525K	Buy	13,965 +6,390	+84%	+$235K	0.22%	99
2017 Q3	$276K	Buy	7,575 +750	+11%	+$28.6K	0.12%	122
2017 Q2	$269K	Hold	6,825	–	–	0.12%	126
2017 Q1	$214K	Buy	+6,825	New	+$214K	0.11%	132

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Compton Capital Management's EW Position: Q4 2022 in Review

Compton Capital Management sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 4,015 shares — an estimated $332K sold.

Compton Capital Management first reported a position in EW in Q1 2017 and held it in 23 quarters. The position peaked at $790K in Q1 2019. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Compton Capital Management reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
Compton Capital Management sold 4,015 Edwards Lifesciences shares in Q4 2022, an estimated $332K.
Compton Capital Management first reported a position in Edwards Lifesciences in Q1 2017 and held it in 23 quarters.
Compton Capital Management's Edwards Lifesciences position peaked at $790K in Q1 2019.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Compton Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.